- Home
- WKHS vs IGC Comparison
WKHS vs IGC Comparison
Compare WKHS & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKHS
- IGC
- Stock Information
- Founded
- WKHS 2007
- IGC 2005
- Country
- WKHS United States
- IGC United States
- Employees
- WKHS N/A
- IGC N/A
- Industry
- WKHS Auto Manufacturing
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- WKHS Consumer Discretionary
- IGC Health Care
- Exchange
- WKHS Nasdaq
- IGC Nasdaq
- Market Cap
- WKHS 20.0M
- IGC 39.8M
- IPO Year
- WKHS N/A
- IGC N/A
- Fundamental
- Price
- WKHS $1.11
- IGC $0.41
- Analyst Decision
- WKHS Hold
- IGC Strong Buy
- Analyst Count
- WKHS 2
- IGC 2
- Target Price
- WKHS $8.68
- IGC $4.00
- AVG Volume (30 Days)
- WKHS 756.2K
- IGC 1.3M
- Earning Date
- WKHS 08-15-2025
- IGC 11-11-2025
- Dividend Yield
- WKHS N/A
- IGC N/A
- EPS Growth
- WKHS N/A
- IGC N/A
- EPS
- WKHS N/A
- IGC N/A
- Revenue
- WKHS $10,745,014.00
- IGC $1,327,000.00
- Revenue This Year
- WKHS $92.70
- IGC $15.26
- Revenue Next Year
- WKHS $34.00
- IGC $3.41
- P/E Ratio
- WKHS N/A
- IGC N/A
- Revenue Growth
- WKHS 11.73
- IGC 24.95
- 52 Week Low
- WKHS $0.81
- IGC $0.25
- 52 Week High
- WKHS $24.25
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- WKHS 31.22
- IGC 51.81
- Support Level
- WKHS $1.13
- IGC $0.38
- Resistance Level
- WKHS $1.34
- IGC $0.44
- Average True Range (ATR)
- WKHS 0.07
- IGC 0.03
- MACD
- WKHS -0.00
- IGC -0.00
- Stochastic Oscillator
- WKHS 3.57
- IGC 32.33
About WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.